Form 8-K · Current Report · Filed 2025-01-15
Intuitive Surgical Reports Preliminary Q4 and Full Year 2024 Financial Results
On January 15, 2025, Intuitive Surgical, Inc.
- Filer
- Intuitive Surgical, Inc. ISRG · NASDAQ
- Filed
- Accession
- 0001035267-25-000005
- CIK
- 0001035267
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
announced preliminary unaudited fourth quarter and full year 2024 financial results. The company also provided unaudited preliminary revenue and procedure information, which is available as Exhibit 99.2 to this 8-K filing.
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$538.88
Next session
+8.4%
Since filing
-34.4%
Latest close
$353.33
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from ISRG reporting the same item, with the next session's move:
Exhibits (2)
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
Never miss another ISRG filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.